FDA+ roundup: Lessons learned from two quality ratings pilots; Expanded FDA collab with organ-on-a-chip company
The FDA since at least 2019 has been fiddling with the idea of adding drug/active pharmaceutical ingredient (API) manufacturing quality ratings or scores as part …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
